Stocks
Dicerna Pharmaceuticals (DRNA) EBITDA margin US GAAP (year values) |
|||||||||
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -19 889% | -2 603% | -1 416% | -498.7% | -67.3% | -61.5% | ||
| Changes by years, y/y, % | +13 867pp | +17 286pp | +1 187pp | +918pp | +431pp | -71.2% | |||
Dicerna Pharmaceuticals. EBITDA margin, %
Dicerna Pharmaceuticals. EBITDA margin, changes, pp
Dicerna Pharmaceuticals (DRNA) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2020Q3 | FY2020Q4 | FY2021Q1 | FY2021Q2 | FY2021Q3 | LTM ? | |||
| EBITDA margin, % | ? | -43.6% | -87.9% | -61.2% | -93.4% | -23.5% | -61.5% | |
| Changes by years, y/y, % | +335pp | +467pp | +3pp | -16pp | +20pp | |||
| Changes by quarters, q/q, % | +34pp | -44pp | +27pp | -32pp | +70pp | |||
